Skip Navigation



NDT Advance Access published online on May 3, 2007

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm252
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/9/2549    most recent
gfm252v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nakhjavani, M.
Right arrow Articles by Zahraei, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakhjavani, M.
Right arrow Articles by Zahraei, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The relationship between the insertion/deletion polymorphism of the ACE gene and hypertension in Iranian patients with type 2 diabetes

Manouchehr Nakhjavani1, Fatemeh Esfahanian1, Alireza Jahanshahi1, Alireza Esteghamati1, Abdol Rahim Nikzamir2, Armin Rashidi1 and Mahin Zahraei2

1Endocrine and Metabolism Research Center, Vali-Asr Hospital and 2Department of Biochemistry, School of Medicine, Medical Sciences, University of Tehran, Tehran, Iran

Correspondence and offprint requests to: Armin Rashidi, No 12, Aramesh Alley, Mellat Park, Tehran, Iran. Email: rasidiarmin{at}yahoo.com



  Abstract

Background. Observations on the association between the ACE gene polymorphism and hypertension have been inconsistent, which might be due to ethnic and geographical variations. Moreover, the relationship between insertion/deletion (I/D) polymorphism and hypertension in the diabetic population has not been sufficiently studied. The aim of this study was to evaluate for the first time the possible association between I/D polymorphism and hypertension in an Iranian diabetic adult population.

Methods. A total of 82 consecutive patients with type 2 diabetes and hypertension (Group A) and 87 patients with type 2 diabetes but without hypertension (Group B) were included. Patients who had a history of hypertension before the onset of diabetes and those with findings suggesting secondary hypertension were excluded. The following variables were determined for each patient: age, sex, body mass index (BMI), diabetes duration and the drugs used, history of coronary artery disease and its complications, blood pressure (systolic and diastolic), fasting blood sugar (FBS), haemoglobin A1c (HbA1c), total cholesterol (Chol), low-density lipoproteins (LDL), high-density lipoproteins (HDL), triglycerides (TG), plasma creatinine (Crt) and 24 h urine albumin excretion. Polymerase chain reaction (PCR) was used to detect the I/D alleles. Univariate (chi-squared and t-test) and multivariate (multivariate binary logistic regression with adjusted odds ratios) analyses were applied to determine the association between I/D polymorphism (with genotype II as reference) and hypertension. P < 0.05 was considered statistically significant.

Results. In univariate analysis, the groups were statistically similar in all variables except for diabetes duration (156.05 ± 73.54 months in Group A vs 121.74 ± 65.53 months in Group B; P = 0.002), Crt (1.04 ± 0.25 mg/dl in Group A vs 0.93 ± 0.23 mg/dl in Group B; P = 0.003), albuminuria (486.25 ± 484.60 mg/d in Group A vs 316.50 ± 459.56 mg/d in Group B; P = 0.021) and the frequency of DD genotype (27 cases in Group A vs 11 cases in Group B; P = 0.026). Multivariate logistic regression (using age, sex and BMI as clinically significant variables and diabetes duration, Crt, albuminuria and genotype as statistically significant variables) was then used to determine independent associations and adjusted odds ratios (OR). The DD genotype was the strongest independent predictor of hypertension [P = 0.029, OR = 3.122, 95% confidence interval (CI) = 1.127–8.647], followed by log (albuminuria) (P = 0.042, OR = 1.183, 95% CI = 1.006–1.391). Considering albuminuria as a categorical variable did not change the results significantly.

Conclusion. The DD polymorphism in the ACE gene is independently associated with hypertension in the diabetic population.

Keywords: albuminuria; ACE; diabetes; hypertension; polymorphism

Received for publication: 1.10.06
Accepted in revised form: 2. 4.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. Nikzamir, A. Esteghamati, M. Feghhi, M. Nakhjavani, A. Rashidi, and Javad Zavar Reza
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2009; 10(2): 109 - 114.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.